What mattered last week and a preview of the week ahead

What mattered last week: U.S. stocks finished higher for a fifth straight week on the back of progress on U.S. – China trade negotiations, talk of tariff rollbacks and better than expected U.S. September quarter earnings. Which prompted a flow of money out of safe-haven assets including gold and bonds. Gold finished the week -3.50% lower near $1460. Yields on U.S. 10 year bonds closed near 1.95%, to record their highest close in 14 weeks.


What mattered last week:

  • U.S. stocks finished higher for a fifth straight week on the back of progress on U.S. – China trade negotiations, talk of tariff rollbacks and better than expected U.S. September quarter earnings.
  • Which prompted a flow of money out of safe-haven assets including gold and bonds.
  • Gold finished the week -3.50% lower near $1460. Yields on U.S. 10 year bonds closed near 1.95%, to record their highest close in 14 weeks.
  • The RBA left interest rates on hold at 0.75% as expected and maintained a clear easing bias.
  • In its Statement on Monetary Policy, the RBA downgraded GDP and inflation forecasts, a combination that does little to improve the prospects for the economy to return to full employment or the RBA to achieve its inflation target.
  • Locally, the ASX200, reversed most of the previous weeks fall to close +0.80%, near 6725 as the choppy sideways price action, driven by sector rotation continued.
  • Economic downgrades by the RBA saw the AUDUSD ease from recent highs to close the week near .6850.

For the week ahead, the key events are:

Australia: NAB business confidence (Tuesday), Westpac consumer confidence and wage price index (Wednesday), employment (Thursday).

  • Employment (Thur): The market is looking for a 15k rise in employment which won’t be enough to prevent the unemployment rate from ticking back up to 5.3%.

New Zealand: Business inflation expectations (Tuesday), RBNZ interest rate meeting (Wednesday), Business NZ PMI (Friday).

  • RBNZ interest rate meeting (Wed): With the market already priced for 21bp of easing the RBNZ is expected to cut the OCR by 25bp to 0.75%.

China: Fixed asset investment, industrial production, retail sales, new yuan loans, total social financing (Thursday).

Japan: GDP Q3 (Thursday), industrial production (Friday).

U.S.: CPI (Thursday), retail sales and industrial production (Friday).

  • Retail sales (Fri): Retail sales are expected to rise by +0.2% in October after falling by -0.3% in September.

September quarter earnings reporting season winds up this week with reports from Walmart, Cisco, and Walt Disney.

Canada: New housing price index (Friday).

Euro Area: EA and German ZEW economic survey (Tuesday), EA industrial production (Wednesday), EA and German GDP Q3 (Thursday), balance of trade (Friday).

UK: GDP, industrial production (Monday), employment (Tuesday), CPI and PPI (Wednesday), retail sales (Thursday).

Disclaimer

TECH-FX TRADING PTY LTD (ACN 617 797 645) is an Authorised Representative (001255203) of JB Alpha Ltd (ABN 76 131 376 415) which holds an Australian Financial Services Licence (AFSL no. 327075)

Trading foreign exchange, futures and CFDs on margin carries a high level of risk and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest in foreign exchange, futures or CFDs you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss in excess of your deposited funds and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with foreign exchange, futures and CFD trading, and seek advice from an independent financial advisor if you have any doubts. It is important to note that past performance is not a reliable indicator of future performance.

Any advice provided is general advice only. It is important to note that:

  • The advice has been prepared without taking into account the client’s objectives, financial situation or needs.
  • The client should therefore consider the appropriateness of the advice, in light of their own objectives, financial situation or needs, before following the advice.
  • If the advice relates to the acquisition or possible acquisition of a particular financial product, the client should obtain a copy of, and consider, the PDS for that product before making any decision.

Related Articles

Join our live webinars for the latest analysis and trading ideas. Register now

GAIN Capital UK Limited (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.